Haisco Pharmaceutical Group Co., Ltd.
Clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd., explained in plain language.
-
New pill shows promise against fatty liver disease in Mid-Stage trial
Disease control CompletedThis study tested an experimental drug called HSK31679 in 186 Chinese adults with non-alcoholic steatohepatitis (NASH), a serious fatty liver disease that can lead to scarring. Participants took either 80 mg, 160 mg, or a placebo daily for 52 weeks. The goal was to see if the dru…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
New pill aims to slow lung scarring in fibrosis patients
Disease control CompletedThis study tested an experimental tablet called HSK44459 in 186 adults aged 40 and older with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and breathing difficulty. The main goal was to see if the drug improves lung function measured by a breathing tes…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New pill could help PNH patients with persistent anemia
Disease control CompletedThis study tested a new tablet, HSK39297, in 36 adults with paroxysmal nocturnal hemoglobinuria (PNH) who still had anemia despite standard treatment. The goal was to see if the drug could raise hemoglobin levels and reduce the need for blood transfusions. Participants took the t…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
New PNH pill shows promise in Head-to-Head trial
Disease control CompletedThis study tested a new pill called HSK39297 against a standard infusion drug (eculizumab) in 73 adults with PNH, a rare blood disorder. The goal was to see if the pill could raise hemoglobin levels and reduce the need for blood transfusions. Participants had not received prior c…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
New inhaler shows promise for COPD patients in phase 3 trial
Disease control CompletedThis study tested a new inhaled medicine called HL231 in 487 Chinese adults with moderate to very severe COPD. The goal was to see if HL231 works better than an existing treatment (Ultibro) at improving lung function and reducing flare-ups over 26 to 52 weeks. Participants inhale…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New injection may ease pain after hip surgery
Symptom relief CompletedThis study tested a new medicine called HSK21542 for pain after hip replacement surgery. 161 adults were randomly assigned to receive HSK21542, morphine, or a placebo. The goal was to see how well the new drug reduces pain and how safe it is compared to standard treatments.
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 08:19 UTC
-
New nerve pain drug shows promise in Year-Long trial
Symptom relief CompletedThis study tested the long-term safety and effectiveness of HSK16149 capsules in 301 Chinese patients with peripheral neuralgia (nerve pain) over 52 weeks. Participants had previously completed a shorter study of the same drug. Researchers monitored side effects, lab results, and…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 08, 2026 12:01 UTC
-
Generic Parkinson's drug put to the test against Brand-Name in healthy volunteers
Knowledge-focused CompletedThis study tested whether a generic version of pramipexole extended-release tablets works the same as the brand-name drug MIRAPEX ER in healthy Chinese volunteers. 49 participants took a single dose of each version under fasting and fed conditions. The goal was to check if the ge…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 08:55 UTC
-
Healthy volunteers test new Pill's reaction to food
Knowledge-focused CompletedThis study looked at how taking a new drug called HSK47388 with or without food changes the way the body absorbs it. Fifteen healthy adults took part in this early-stage trial. The main goal was to understand the drug's safety and how it moves through the body, not to treat any d…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 08:53 UTC
-
Generic HIV drug matches brand in healthy chinese study
Knowledge-focused CompletedThis study checked if a generic version of tenofovir disoproxil fumarate (a drug used for HIV and hepatitis B) works the same as the brand-name drug Viread. Forty-seven healthy Chinese adults took both versions under fasting and fed conditions. The goal was to see if the generic …
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
Generic numbing cream matches brand in small Healthy-Volunteer study
Knowledge-focused CompletedThis study compared a generic numbing cream (lidocaine and prilocaine) to the brand-name EMLA cream in 40 healthy adults. The goal was to see if the generic version enters the bloodstream at the same rate and amount as the brand-name cream. Participants received both creams at di…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC